Ubs Asset Management Americas Inc Legend Biotech Corp Transaction History

Ubs Asset Management Americas Inc

$379 Billion
Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 113,455 shares of LEGN stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

113,455

Previous 136,438 16.85%

Holding current value

$3.41 Million

Previous $4.44 Million 13.29%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 19, 2025	SELL	$31.43 - $39.7 $722,355 - $912,425	-22,983 Reduced 16.85%	113,455 $3.85 Million
Q4 2024 Feb 14, 2025	BUY	$32.49 - $50.28 $1.18 Million - $1.82 Million	36,181 Added 36.09%	136,438 $4.44 Million
Q3 2024 Nov 14, 2024	SELL	$43.55 - $59.88 $273,319 - $375,806	-6,276 Reduced 5.89%	100,257 $4.89 Million
Q2 2024 Aug 13, 2024	SELL	$39.5 - $57.22 $8.84 Million - $12.8 Million	-223,790 Reduced 67.75%	106,533 $4.72 Million
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $1.65 Million - $2.09 Million	29,917 Added 9.96%	330,323 $18.5 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $2.18 Million - $2.65 Million	38,001 Added 14.48%	300,406 $18.1 Million
Q3 2023 Nov 13, 2023	BUY	$63.16 - $76.5 $3.03 Million - $3.67 Million	47,947 Added 22.36%	262,405 $17.6 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $1.39 Million - $1.83 Million	31,961 Added 17.51%	214,458 $10.3 Million
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $12.1 Million - $17.3 Million	-312,379 Reduced 63.12%	182,497 $9.11 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $371,466 - $555,982	9,737 Added 2.01%	494,876 $20.2 Million
Q2 2022 Aug 12, 2022	BUY	$33.54 - $55.0 $10.7 Million - $17.6 Million	320,007 Added 193.79%	485,139 $26.7 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $1.39 Million - $2.16 Million	44,798 Added 37.23%	165,132 $6 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $4.95 Million - $6.86 Million	120,334 New	120,334 $5.61 Million
Q3 2020 Nov 13, 2020	SELL	$27.5 - $39.61 $687,500 - $990,250	-25,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $902,500 - $1.06 Million	25,000 New	25,000 $1.06 Million

Others Institutions Holding LEGN

# of Institutions

229

Shares Held

74.4M

Call Options Held

247K

Put Options Held

406K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.03B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Legend Biotech Corp Transaction History